Economic Evaluation of New MDR TB Regimens

Clinical trial NCT04207112 · COMPLETED

Trial details

NCT number: NCT04207112
Sponsor: Medecins Sans Frontieres, Netherlands
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multi-drug Resistant Tuberculosis Extensively Drug-Resistant Tuberculosis Pulmonary Tuberculoses

Start date: 2020-10-20
Primary completion: 2022-08-25
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.